HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NTproCNP

aminoterminal propeptide

Networked: 13 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Peptide Hormones: 1347
    - Natriuretic Peptides: 3754
      - C-Type Natriuretic Peptide: 273
        NTproCNP: 13
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Peptide Hormones: 1347
    - Natriuretic Peptides: 3754
      - C-Type Natriuretic Peptide: 273
        NTproCNP: 13

Experts

1.	Espiner, Eric A: 7 articles (01/2022 - 11/2012)
2.	Prickett, Timothy C R: 7 articles (01/2022 - 11/2012)
3.	Olney, Robert C: 3 articles (01/2022 - 11/2012)
4.	Troughton, Richard W: 3 articles (01/2020 - 01/2018)
5.	Espiner, E A: 3 articles (08/2015 - 02/2012)
6.	Bober, Michael B: 2 articles (01/2022 - 02/2015)
7.	Duker, Angela L: 2 articles (01/2022 - 02/2015)
8.	Mackenzie, William G: 2 articles (01/2022 - 02/2015)
9.	Cameron, Vicky A: 2 articles (01/2019 - 01/2018)
10.	Prickett, T C R: 2 articles (08/2015 - 04/2014)

Related Diseases

1.	Klinefelter Syndrome (Klinefelter's Syndrome) 11/01/2012 - "Plasma levels of NTproBNP and CNP were lower, whereas levels of NTproCNP were higher in boys with Klinefelter syndrome compared with published reference ranges. " 11/01/2012 - "The objectives of the study were to document the blood levels of amino-terminal propeptide of B-type natriuretic peptide (NTproBNP), CNP, and its amino-terminal propeptide (NTproCNP) in boys with Klinefelter syndrome and compare values with age- and height-matched control subjects. "
2.	Metabolic Bone Diseases (Osteopenia) 05/01/2023 - "Using stored plasma samples from a previous randomized controlled clinical trial (RESHAW) of resveratrol supplementation in postmenopausal women exhibiting mild osteopenia, we have studied changes in plasma aminoterminal proCNP (NTproCNP) and concurrent change in bone turnover markers of formation (osteocalcin [OC] and alkaline phosphatase [ALP]) and resorption (C-terminal telopeptide type 1 collagen [CTX]) with bone mineral density (BMD) over a 2-year period of study in 125 subjects. "
3.	Pre-Eclampsia (Preeclampsia) 10/01/2018 - "Significant predictive power of single time point measurements of NTproCNP for predicting short-term occurrence of preeclampsia in asymptomatic women was found in weeks 28-32 (p = .023) and 33-36 (p = .014). " 08/01/2015 - "Plasma NTproCNP measurements may have clinical application in late pregnancy in defining the different phenotypes associated with pre-eclampsia." 08/01/2015 - "Maternal plasma amino terminal proCNP (NTproCNP) was measured by radioimmunoassay in early (14-16 weeks of gestation, and again at 19-21 weeks of gestation) and late (34-36 weeks of gestation) pregnancy in three groups of women (20 per group): pre-eclampsia (pre-eclampsia); gestational hypertension (GHT) with small for gestational age (SGA); and uncomplicated pregnancy. " 10/01/2018 - "To evaluate serum levels of the amino-terminal propeptide of C-type natriuretic peptide (NTproCNP) in uneventful pregnancies and pregnancies complicated by preeclampsia (PE) and NTproCNP's accuracy for prediction of PE. "
4.	Achondroplasia 02/01/2015 - "Levels were also elevated in adults with achondroplasia (CNP SDSs of 1.5 [0.7-2.1] and NTproCNP SDSs of 0.5 [0.1-1.0], P < .005). " 02/01/2015 - "Plasma levels of CNP and NTproCNP were higher in children with achondroplasia with CNP SD scores (SDSs) of 1.0 (0.3-1.4) (median [interquartile range]) and NTproCNP SDSs of 1.4 (0.4-1.8; P < .0005). " 01/01/2022 - "Using the same cohort in which CNP and NTproCNP levels were previously measured, archived serum aliquots from 63 children with achondroplasia, six with hypochondroplasia, and two with thanatophoric dysplasia had CXM concentrations measured. " 01/01/2022 - "Plasma C-type natriuretic peptide (CNP) and NTproCNP levels have also been found to correlate with growth velocity in the general population and are elevated in individuals with achondroplasia compared with age- and sex-matched controls. "
5.	Acute Coronary Syndrome 01/01/2020 - "In a prospective study of 66 subjects with or without post- acute coronary syndrome (ACS), plasma concentrations of bioactive CNP and bio-inactive aminoterminal proCNP (NTproCNP), ET-1, B-type Natriuretic Peptide (BNP) and high sensitivity C Reactive Protein (hsCRP) were measured together with lipids before and at intervals of 1, 2 and 7 days after commencing atorvastatin 40 mg/day - and for a further period of 6months in those with ACS. "

Related Drugs and Biologics

1.	pro-brain natriuretic peptide (1-76)
2.	Brain Natriuretic Peptide (Natrecor)
3.	Alkaline Phosphatase
4.	Collagen Type I (Type I Collagen)
5.	Osteocalcin
6.	Resveratrol
7.	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)
8.	Human Growth Hormone (Saizen)
9.	Lipids
10.	Insulin-Like Growth Factor I (IGF-1)

Related Therapies and Procedures

1.	Therapeutics
2.	Aftercare (After-Treatment)